Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Infectious Diseases

• Publication date

  2015-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cid/civ019PMID 25697739PMCID PMC4447778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Missing data

  2019cited by this paper
• Interim estimates of 2013-14 seasonal influenza vaccine effectivenes : data from the U.S. Flu VE Network, December 2, 2013 – January 23, 2014

  2014cited by this paper
• Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014

  2014cited by this paper
• Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.

  2014cited by this paper
• In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen

  2014cited by this paper
• Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season.

  2013influential reference
• Update: influenza activity--United States, September 30-November 24, 2012.

  2012cited by this paper
• Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

  2012cited by this paper
• Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.

  2011cited by this paper
• Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities

  2011cited by this paper
• Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults.

  2011influential reference
• Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study

  2011cited by this paper
• Regularization Paths for Generalized Linear Models via Coordinate Descent.

  2010cited by this paper
• In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.

  2009influential reference
• "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9.

  2009cited by this paper
• T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1

  2006influential reference
• Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly.

  2002cited by this paper
• Human Cytotoxic T-Lymphocyte Repertoire to Influenza A Viruses

  1998cited by this paper
• Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines

  1998influential reference
• Activities of the International Federation of Pharmaceutical Manufacturers Associations in world health.

  1991cited by this paper
• Field evaluation of vaccine efficacy.

  1985cited by this paper

• A mosaic H3 subtype live attenuated influenza vaccine elicits broad immune responses to influenza a viruses.

  2025cites this paper
• Chronic Diseases and Influenza Vaccines

  2025cites this paper
• A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months

  2024cites this paper
• Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza

  2024cites this paper
• Challenges in the Vaccination of the Elderly and Strategies for Improvement

  2023cites this paper
• Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.

  2022cites this paper
• Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology

  2022cites this paper
• In vitro approaches for the evaluation of human vaccines

  2021cites this paper
• Glycoconjugates for Adjuvants and Self-Adjuvanting Vaccines

  2021cites this paper
• In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus

  2021cites this paper
• Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production

  2021cites this paper
• Influenza Vaccination in Older Adults

  2021cites this paper
• Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives

  2020cites this paper
• The Power of First Impressions: Can Influenza Imprinting during Infancy Inform Vaccine Design?

  2020influential citation
• Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice

  2020cites this paper
• Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly

  2020cites this paper
• The immune response to influenza in older humans: beyond immune senescence

  2020cites this paper
• Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.

  2019cites this paper
• Influenza Vaccination in Older Adults

  2019cites this paper
• The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.

  2019cites this paper
• The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology.

  2019cites this paper
• Comparison of Split versus Subunit Seasonal Influenza Vaccine in Korean Children over 3 to under 18 Years of Age

  2019cites this paper
• Impfungen: Interaktive Fälle zu den STIKO-Empfehlungen 2017

  2018cites this paper
• Influenza hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection for influenza B.

  2018cites this paper
• Résumé de l'examen de la littérature du Comité consultatif national sur l'immunisation (CCNI) sur l'efficacité comparative des vaccins antigrippaux inactivés sous-unitaires et à virions fragmentés chez les personnes âgées

  2018influential citation
• Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults.

  2018influential citation
• EFFECTS OF VACCINE PLATFORMS AND ADJUVANTS ON PROTECTIVE EFFICACY AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS

  2018cites this paper
• A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries

  2017cites this paper
• Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults.

  2017cites this paper
• 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project

  2017cites this paper
• Sensitive Diagnostics Confirm That Influenza C is an Uncommon Cause of Medically Attended Respiratory Illness in Adults

  2017cites this paper
• GENETIC CHANGES- A CHARACTERISTIC OF INFLUENZA VIRUSES

  2017cites this paper
• The life cycle of a T cell after vaccination – where does immune ageing strike?

  2017cites this paper
• T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines

  2016cites this paper
• Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.

  2016cites this paper
• Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?

  2016cites this paper
• Recommendations for Vaccination Against Seasonal Influenza in Adult High Risk Groups: South Asian Recommendations.

  2016cites this paper